Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On December 3, 2025, Clene Inc. issued a press release announcing statistically significant amyotrophic lateral sclerosis (“ALS”) biomarker result
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 99.1 Press release, dated December 3, 2025, announcing statistically signific